Bluejay Diagnostics Inc. (NASDAQ: BJDX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BLUEJAY DIAGNOSTICS INC.

Bluejay Diagnostics Inc. (NASDAQ: BJDX)
Listen to this Section


$4.82
-0.0690 ( -1.41% ) 41.4K

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

Market Data


Open $4.82
Previous Close $4.89
Volume 41.4K
Market Cap $5.06M
Day Range $4.69 - $4.90
52 Week Range $1.62 - $16.68
Shares Outstanding 1.03M
Change % -1.41%
Net Change ▼ -0.0690
Insider Ownership N/A
Exchange NASDAQ
SectorHealthcare
IndustryMedical Specialities
IPO Year2021
CountryUnited States
UnderwriterDawson James, I-Bankers Securities, ViewTrade, more

Insider Ownership Transactions

Total Amount Purchased: 1,000.00

Date Type Amount Purchased Purchaser
2023-12-14 Buy 500.00 Dey Indranil
2023-12-14 Buy 500.00 Dey Svetlana

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Apr 07, 2026
8-k 8K-related 13 Mar 17, 2026
8-k 8K-related 15 Mar 16, 2026
8-k 8K-related 15 Mar 12, 2026
schedule Other 4 Mar 11, 2026
schedule Other 4 Mar 11, 2026
schedule Other 4 Mar 11, 2026
10-k Annual reports 74 Mar 06, 2026
8-k 8K-related 15 Mar 06, 2026
8-k 8K-related 15 Feb 20, 2026

Latest News


× Before browsing our site, please accept our cookies policy